




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Vascular Medicine</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=0b213bea-9a50-4a88-aa7f-678a7be1de93</link>
        <description>Clinical Topic Feed: Vascular Medicine</description>
        <language>en</language>

        

                <item>
                    <title>ACC Latin America 2026 Highlights Sex-Based Disparities in STEMI, Research Addressing CV Risk and Care Across the Region</title>
<link>/Latest-in-Cardiology/Articles/2026/09/16/18/36/ACC-Latin-America</link>                    <description>New science focused on health disparities, cardiovascular risk factors and opportunities to improve patient outcomes will be among the topics as experts and cardiovascular clinicians from around Latin America and the U.S. come together at ACC Latin America 2026, in Medell&#195;&#173;n, Colombia, from Sept. 17 to Sept. 19.</description>
                    <pubdate>1789646400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>SirPAD Redefines Drug-Coated Balloon Therapy in PAD</title>
<link>/Latest-in-Cardiology/Articles/2026/09/14/16/12/SirPAD-Redefines-Drug-Coated-Balloon-Therapy-in-PAD</link>                    <description>Peripheral artery disease (PAD) affects &amp;gt;113 million people worldwide and remains a major cause of limb loss, cardiovascular morbidity, and cardiovascular mortality.</description>
                    <pubdate>1789409820000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HI-PEITHO and the Evolution of Reperfusion Strategies in Pulmonary Embolism</title>
<link>/Latest-in-Cardiology/Articles/2026/09/08/14/17/HI-PEITHO-and-the-Evolution-of-Reperfusion-Strategies-in-Pulmonary-Embolism</link>                    <description>Management of intermediate-risk pulmonary embolism (PE) remains one of the most challenging areas in venous thromboembolism care. These patients are hemodynamically stable but have right ventricular (RV) dysfunction and myocardial injury, placing them at increased risk of clinical deterioration.</description>
                    <pubdate>1788962340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement from the American College of Cardiology and the American Heart Association</title>
<link>https://www.jacc.org/doi/10.1016/j.jacc.2026.07.003</link>                    <description></description>
                    <pubdate>1788458400000</pubdate>
                    <category>Guidelines</category>
                </item>
                <item>
                    <title>ACC/AHA Scientific Statement Focuses on CV Risk Evaluation, Management For Tactical Athletes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/03/15/11/ACC-AHA-Scientific-Statement-Focuses-on-CV-Risk-Evaluation-Management-For-Tactical-Athletes</link>                    <description>A new ACC/AHA Scientific Statement provides the first comprehensive framework for cardiovascular evaluation and management of tactical athletes, including the more than 4 million Americans currently serving as military personnel, firefighters, law enforcement officers, EMS professionals, pilots and astronauts.</description>
                    <pubdate>1788458400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For September 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1788305160000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CorCal Outcomes, EVAOLD, ISOLEDS Inform CV Risk Prediction, Post-MI Treatment and Stenting Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-730am-corcal-evaold-isoleds-esc-2026</link>                    <description>Cardiovascular prevention, acute care and interventional cardiology converged in a wide-ranging Hot Line Session at ESC Congress 2026 that delivered new evidence on how clinicians assess risk, treat older heart attack patients and guide complex coronary procedures.</description>
                    <pubdate>1788177780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PADN-HF-PH: Pulmonary-Artery Denervation For Pulmonary Hypertension Associated With Left Heart Disease and HF</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-324am-padn-esc-2026</link>                    <description>Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension associated with left heart disease and heart failure (HF), based on findings from the PADN-HF-PH trial presented at ESC Congress 2026 and simultaneously published in NEJM.</description>
                    <pubdate>1788082020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>NATURE Superiority: Stent Retriever Thromboectomy Plus PCI in Patients With MI</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-nature-esc-2026</link>                    <description>Compared with conventional PCI alone, stent-retriever thrombectomy followed by PCI was associated with reduced infarct size in patients with large thrombus burden undergoing primary PCI less than eight hours from symptom onset, based on findings from the NATURE Superiority study presented at ESC Congress 2026 and simultaneously published in JACC.</description>
                    <pubdate>1788016800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AIR-STEMI, PRESC1SE-MI and TARGET CTA Highlight Critical Care Cardiology Science</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-11am-combo-ccc-esc-2026</link>                    <description>Researchers presenting findings from the AIR-STEMI trial at ESC Congress 2026 said a strategy of complete coronary artery revascularization guided by functional coronary angiography resulted in a lower risk of death, myocardial infarction (MI), cerebrovascular accident, or ischemia-driven revascularization in patients with STEMI and multivessel coronary artery disease compared with conventional angiography.</description>
                    <pubdate>1788016560000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>